GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Real Brands Inc (OTCPK:RLBD) » Definitions » Beta

Real Brands (Real Brands) Beta : -0.17 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Real Brands Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-14), Real Brands's Beta is -0.17.


Real Brands Beta Historical Data

The historical data trend for Real Brands's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Real Brands Beta Chart

Real Brands Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.42 0.37 0.62 0.16 -0.29

Real Brands Quarterly Data
Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 -0.45 -0.57 -0.19 -0.29

Competitive Comparison of Real Brands's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Real Brands's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Real Brands's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Real Brands's Beta distribution charts can be found below:

* The bar in red indicates where Real Brands's Beta falls into.



Real Brands Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Real Brands  (OTCPK:RLBD) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Real Brands Beta Related Terms

Thank you for viewing the detailed overview of Real Brands's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Real Brands (Real Brands) Business Description

Traded in Other Exchanges
N/A
Address
12 Humbert Street, North Providence, RI, USA, 02991
Real Brands Inc is a brand-building company in the legal hemp and cannabis industry. Its brand includes CBD Pharmacy, Omega Hemp, Hempaid, and Humboldt among others. The company sells its hemp-based products to the wholesale and retail markets.
Executives
James Wells Dobbins director 5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Thomas Kidrin officer: President and CEO 11 ROYAL ROAD, BROOKLINE MA 02445
Christopher John Ryan officer: CFO 11 ROYAL RD, BROOKLINE MA 02445
Leonard Toboroff director 39 N MOORE ST, STE 6B, NEW YORK NY 10013
Peter N Christos director
Turning Point Brands, Inc. 10 percent owner 5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Brett S. Spitalny officer: Chief Operating Officer 2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Jerry Pearring director, officer: President & CEO 2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Ross E Silvey director 7633 EAST 63RD PLACE, #220, TULSA OK 74133
Terry J Turner director 7633 EAST 63RD PLACE, #220, TULSA OK 74133
Bernie Gurr officer: Chief Financial Officer 32751 MATTHEW DRIVE, DANA POINT CA 92629
Bruce Macgregor officer: Chief Executive Officer, Pres. 5092 RHOADS AVENUE UNIT A, SANTA BARBARA CA 93111
Ken Wiedrich director 43180 BUSINESS PARK DRIVE SUITE 202, TEMECULA CA 92590

Real Brands (Real Brands) Headlines

From GuruFocus

RLBD's Kidrin on Revs, M&A, and TPB

By ACCESSWIRE ACCESSWIRE 03-14-2022

Real Brands Inc. Uplists to OTCQB

By GuruFocusNews GuruFocusNews 03-02-2022